News

The dispute between the competitors lasted for more than three years, with each party asserting that the other’s cold sore remedy advertising claims constituted false advertising in violation

The company anticipates the reporting of final results and statistical analysis for the study within the next two to three weeks. The new study concerns assessment of the

Advitech and PL Thomas (PLT) have concluded a non-exclusive distribution agreement with a yearly commitment for Advitech’s XP-828L ingredient, a patent-pending composition consisting of growth factors, especially TGF-

InterStim therapy is a reversible treatment for patients with fecal incontinence after conservative treatments have failed. Once approved by the FDA, InterStim therapy for fecal incontinence will be

The investment, led by Inventages, will advance continued development of the Neuroptix Sapphire diagnostic platform and related technologies. The Neuroptix Sapphire system consists of a non-contact optical device

Dr Khvorova has previously served as chief scientific officer at Dharmacon, a developer and supplier of RNAi compounds. Prior to Dharmacon, Dr Khvorova served as research scientist with

Olmesartan medoxomil hydrochlorothiazide tablets, indicated for the treatment of high blood pressure, are the generic version of Daiichi Sankyo’s Benicar HCT. Mylan Pharmaceuticals has previously submitted its original

Under the terms of the agreement, AlphaRx will use its proprietary nano drug delivery platforms to formulate two injectable products targeting underserved medical conditions. These represent market opportunities

As part of the agreement, the Juvenile Diabetes Research Foundation (JDRF) will provide $1 million in first-year funding to support preclinical safety and efficacy testing. The partnership is